Related Experiment Video For Cryptococcosis
Updated: Jul 30, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Disseminated Cryptococcosis in an Immunocompromised Patient with Altered Mental Status and a Lung Nodule
Dena H Tran1,2, Avelino C Verceles1,2, Ellen T Marciniak1,2
1Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, 110 South Paca Street, Baltimore, MD, 21201, USA.
Introduction:
Disseminated cryptococcosis is an opportunistic infection that commonly affects the central nervous and respiratory systems and is often fatal in immunocompromised host patients. Diagnosing disseminated cryptococcosis is challenging at times due to the nonspecific presentation, resulting in delayed treatment and increased mortality.
Case Presentation:
A 48-year-old man presented with altered mental status and shortness of breath requiring intubation. Medical history was significant for rheumatoid arthritis, diabetes mellitus, chronic kidney disease, sarcoidosis, and polymyalgia rheumatica. Home medications included prednisone, methotrexate, and tocilizumab. Computed tomography chest revealed multifocal pneumonia with a cavitary nodule with halo sign. One week after extubation, the patient remained confused. Lumbar puncture (LP) was positive for Cryptococcus neoformans within 5 days. Bronchoalveolar lavage (BAL) yielded similar results on fungal culture one month later.
Conclusion:
An immunocompromised host patient who presents with altered mental status with concomitant lung nodules should have disseminated cryptococcosis as a differential diagnosis. CT chest commonly demonstrate peripheral lung nodules with cavitation, air bronchograms, halo sign, and/or enlarged mediastinal lymphadenopathy, as found in our patient. If the clinical suspicion for disseminated cryptococcosis is high, an LP should be performed, as BAL results may often be delayed since Cryptococcus grows slowly from the lungs. Empiric antifungals should be started immediately, given increased mortality if treatment is delayed.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Fungal Phylum Microsporidia
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

